Report cover image

Interferon Beta Drugs Market, By Product Type (Interferon Beta-1A, Interferon Beta-1B, Peginterferon Beta-1A), By Route Of Administration (IntramuscularIntramuscular, Subcutaneous, Intravenous), By Distribution Channel (Hospitals Pharmacies, Retail Pharma

Publisher Coherent Market Insights
Published Mar 25, 2025
Length 169 Pages
SKU # CMI20007950

Description

Interferon beta drug is used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. The drug does not completely cure the condition, but slows down progression of some of the disabling effects and decreases the number of relapses of the disease. Interferons are natural substances produced in the human body to help fight infections. Interferon beta drugs are categorized in Interferon Beta-1A, Interferon Beta-1B, and Peginterferon Beta-1A.

Market Dynamics

Multiple sclerosis is a widespread disabling neurological condition, mostly diagnosed in people in the age group 20–50 years. According to the Multiple Sclerosis Foundation, in 2017, this autoimmune condition affects 2.5 million people with an annual global incidence of around 7 cases per 100,000 people. The study also states that prevalence rates vary between ethnic and geographical latitudes, ranging from 50 to 120 people per 100,000. Moreover, according to the Multiple Sclerosis Foundation, 2015, an estimated 400,000 people live with the disease in U.S., and about 200 new cases are diagnosed every week. According to a survey by Healthline Media, 2015, multiple sclerosis ranks second after congestive heart failure with direct and indirect health care costs ranging from US$ 8,528 to US$ 54,244 per patient per year. Thus, increasing prevalence of multiple sclerosis is a major factor driving the growth of global interferon beta drugs market.

Key features of the study:
  • This report provides in-depth analysis of the global interferon beta drugs market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global interferon beta drugs market based on the following parameters – company overview, financial performance, drugs portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study are Biogen Idec., Merck KGaA, Novartis Pharmaceuticals Corporation, and Bayer
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The global interferon beta drugs market report caters to various stakeholders in this industry including investors, suppliers, drugs manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global interferon beta drugs market.
Detailed Segmentation:
  • Global Interferon Beta Drugs Market, By Product Type:
  • Interferon Beta-1A
  • Interferon Beta-1B
  • Peginterferon Beta-1A
  • Global Interferon Beta Drugs Market, By Route of Administration:
  • Intramuscular
  • Subcutaneous
  • Intravenous
  • Global Interferon Beta Drugs Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Interferon Beta Drugs Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Company Profiles:
  • Biogen Idec
  • Merck KGaA
  • Novartis Pharmaceuticals Corporation
  • Bayer

Table of Contents

169 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Route Of Administration
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
4. Global Interferon Beta Drugs Market– COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Interferon Beta Drugs Market, By Product Type, 2020–2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
Interferon Beta-1A
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
Interferon Beta-1B
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
Peginterferon Beta-1A
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
6. Global Interferon Beta Drugs Market, By Route Of Administration, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
Intramuscular
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
Subcutaneous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
Intravenous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
7. Global Interferon Beta Drugs Market, By Distribution Channel, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
Hospitals Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
8. Global Interferon Beta Drugs Market, By Region, 2020–2032, (US$ Bn)
Introduction
Market Share Analysis, By Region, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Regions, 2021–2032
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration , 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration , 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration , 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration , 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration , 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration , 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2020–2032, (US$ Bn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Biogen
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Merck KGaA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Novartis AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Bayer AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
10. Section
Research Methodology
About Us
*Browse 35 market data tables and 31 figures on “Interferon Beta Drugs Market” - forecast to 2032

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us